Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0004352 (
autism
)
32,579
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The tumor suppressor PTEN (phosphatase and tensin homolog) plays a critical role in the development and maintenance of the mammalian nervous system. Effects of inherited mutation of PTEN are highly variable and include
macrocephaly
, Lhermitte-Duclos disease (LDD) caused by a hamartomatous enlargement of the cerebellum, ataxia, seizures and
autism
, in addition to cancer predisposition. In the mouse, selective inactivation of Pten in post-mitotic granule neurons of the cerebellum and dentate gyrus showed that Pten was required for proper regulation of neuronal nuclear and soma size. Hypertrophy of Pten-deficient neurons required the activity of the serine-threonine kinase mTor. mTor is a master regulator of cell and organ growth which can trigger a cascade of downstream signaling pathways involving, in part, components of the translational machinery, including S6k1 and its substrate the ribosomal protein S6. Deletion of S6k1 in mice results in decreased size. Therefore, to determine the relative contribution of S6k1 to Pten-deficient neuronal hypertrophy in vivo, we crossed Pten brain-conditional knockouts with S6k1 null mice. Double mutant mice show no reversion or improvement in their Pten-related size and neurological defects including enlarged cerebella and dentate gyri with increased size of neuronal nuclei and somata, ataxia, and premature death. The hypertrophic Pten/S6k1-deficient neurons contained high levels of phosphorylated S6, similar to Pten-deficient neurons, suggesting that the mTor/S6k/S6 branch of the pathway was still active. Thus, we conclude that S6k1 is not required to cause hypertrophy of Pten-deficient neurons. This study reveals a cell type-dependent role for S6k1 in PI3K-dependent hypertrophy.
...
PMID:S6k1 is not required for Pten-deficient neuronal hypertrophy. 1677 79
There has been little exploration of major biologic regulators of cerebral development in
autism
. We measured insulin-like growth factors (IGF) -1 and -2 from cerebrospinal fluid (CSF) by radio immunoassay in 25 children with
autism
(median age 5y 5mo; range 1y 11mo-15y 10mo; 20 males, 5 females), and in 16 age-matched comparison children without disability (median age 7y 4mo; range 1y 1mo-15y 2mo; eight males, eight females). IGF-1 and -2 concentrations were further correlated with age of patients and head size. CSF IGF-1 concentration was significantly lower in patients with
autism
than in the comparison group. The CSF concentrations of children with
autism
under 5 years of age were significantly lower than their age-matched comparisons. The head circumferences correlated with CSF IGF-1 in children with
autism
but no such correlation was found in the comparison group. There was no difference between the two groups in CSF IGF-2 concentrations. No patients with
autism
had
macrocephaly
. We conclude that low concentrations of CSF IGF-1 at an early age might be linked with the pathogenesis in
autism
because IGF-1 is important for the survival of Purkinje cells of the cerebellum. The head growth might be explained by the actions of IGF-1 and -2 reflected in CSF concentrations.
...
PMID:Cerebrospinal fluid insulin-like growth factors IGF-1 and IGF-2 in infantile autism. 1690 22
Data from 10 sites of the NICHD/NIDCD Collaborative Programs of Excellence in
Autism
were combined to study the distribution of head circumference and relationship to demographic and clinical variables. Three hundred thirty-eight probands with
autism
-spectrum disorder (ASD) including 208 probands with
autism
were studied along with 147 parents, 149 siblings, and typically developing controls. ASDs were diagnosed, and head circumference and clinical variables measured in a standardized manner across all sites. All subjects with
autism
met ADI-R, ADOS-G, DSM-IV, and ICD-10 criteria. The results show the distribution of standardized head circumference in
autism
is normal in shape, and the mean, variance, and rate of
macrocephaly
but not microcephaly are increased. Head circumference tends to be large relative to height in
autism
. No site, gender, age, SES, verbal, or non-verbal IQ effects were present in the
autism
sample. In addition to
autism
itself, standardized height and average parental head circumference were the most important factors predicting head circumference in individuals with
autism
. Mean standardized head circumference and rates of
macrocephaly
were similar in probands with
autism
and their parents. Increased head circumference was associated with a higher (more severe) ADI-R social algorithm score.
Macrocephaly
is associated with delayed onset of language. Although mean head circumference and rates of
macrocephaly
are increased in
autism
, a high degree of variability is present, underscoring the complex clinical heterogeneity of the disorder. The wide distribution of head circumference in
autism
has major implications for genetic, neuroimaging, and other neurobiological research.
...
PMID:Head circumference and height in autism: a study by the Collaborative Program of Excellence in Autism. 1702 81
The temporal lobe is thought to be abnormal in
autism
, yet standard volumetric analyses are often unrevealing when age, sex, IQ, and head size are controlled. Quantification of temporal lobe structures were obtained in male subjects with
autism
and controls, where subjects with head circumference (HC) defined
macrocephaly
were excluded, so that volume differences were not just related to the higher prevalence of
macrocephaly
in
autism
. Various statistical methods were applied to the analysis including a classification and regression tree (CART) method, a non-parametric technique that helps define patterns of relationships that may be meaningful in distinguishing temporal lobe differences between subjects with
autism
and age and IQ matched controls. Subjects with
autism
were also compared to a separate control group with reading disorder (RD), with the prediction that the temporal lobe morphometric analysis of the reading disorder controls would be more similar to that of the
autism
group. The CART method yielded a high specificity in classifying
autism
subjects from controls based on the relationship between the volume of the left fusiform gyrus (LFG) gray and white matter, the right temporal stem (RTS) and the right inferior temporal gyrus gray matter (RITG-GM). Reading disordered individuals were more similar to subjects with
autism
. Simple size differences did not distinguish the groups. These findings demonstrate different relationships within temporal lobe structures that distinguish subjects with
autism
from controls. Results are discussed in terms of pathological connectivity within the temporal lobe as it relates to
autism
.
...
PMID:Quantitative temporal lobe differences: autism distinguished from controls using classification and regression tree analysis. 1720 87
Recently, Butler et al. [2005; J Med Genet 42:318-321] reported the presence of heterozygous germline mutations in the PTEN tumor suppressor gene in three children with
autism
and
macrocephaly
. Here, we report the presence of PTEN mutations in two additional unrelated children with
macrocephaly
and
autism
. Our findings extend those of Butler et al. and suggest that PTEN gene sequencing should be included in the genetic evaluation of this subset of autistic individuals.
...
PMID:Increasing knowledge of PTEN germline mutations: Two additional patients with autism and macrocephaly. 1728 65
Mutations in the PTEN gene are associated with a broad spectrum of disorders, including Cowden syndrome (CS), Bannayan-Riley-Ruvalcaba syndrome, Proteus syndrome, and Lhermitte-Duclos disease. In addition, PTEN mutations have been described in a few patients with
autism
spectrum disorders (ASDs) and
macrocephaly
. In this study, we screened the PTEN gene for mutations and deletions in 88 patients with ASDs and
macrocephaly
(defined as >or=2 SD above the mean). Mutation analysis was performed by direct sequencing of all exons and flanking regions, as well as the promoter region. Dosage analysis of PTEN was carried out using multiplex ligation-dependent probe amplification (MLPA). No partial or whole gene deletions were observed. We identified a de novo missense mutation (D326N) in a highly conserved amino acid in a 5-year-old boy with
autism
, mental retardation, language delay, extreme
macrocephaly
(+9.6 SD) and polydactyly of both feet. Polydactyly has previously been described in two patients with Lhermitte-Duclos disease and CS and is thus likely to be a rare sign of PTEN mutations. Our findings suggest that PTEN mutations are a relatively infrequent cause of ASDs with
macrocephaly
. Screening of PTEN mutations is warranted in patients with
autism
and pronounced
macrocephaly
, even in the absence of other features of PTEN-related tumor syndromes.
...
PMID:Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly. 1742 95
An increased prevalence of
macrocephaly
defined by occipital-frontal circumference (OFC) is a consistent finding in
autism
. Several possible mechanisms have been proposed, the most compelling being early brain overgrowth. However, the proportion of non-neural tissues (NNT) that contribute to OFC has not been reported. Using quantitative magnetic resonance imaging (MRI) methods we analyzed the relationships between OFC and total brain (TBV), ventricular, surface cerebrospinal fluid (CSF)/meningeal, and NNT volumes in subjects with
autism
. Sixty male subjects (34 autistic; 26 controls) seven years of age and older were used in this study. Compared to other measures, NNT volume was most significantly related to OFC (r values > 0.8, p<or=0.001), though NNT volume did not differ between the groups. Ventricular volume was also uniformly related to OFC (r approximately 0.3, p> 0.06). In contrast, the OFC-TBV relationship was less robust in those with
autism
(r=0.25, p<or=0.09) and only significant in the controls (r=0.58, p<or=0.001). Conversely, subjects with
autism
had a more robust and significantly different relationship between subarachnoid CSF/meningeal volume than controls (r=0.53 and 0.24; p<or=0.001 and 0.12, respectively). Possible explanations for these findings are discussed in the context of potential OFC differences that may occur in accelerated early brain growth associated with
autism
.
...
PMID:The relative contributions of brain, cerebrospinal fluid-filled structures and non-neural tissue volumes to occipital-frontal head circumference in subjects with autism. 1760 99
Conditional deletion of Pten (phosphatase and tensin homolog on chromosome ten) in differentiated cortical and hippocampal neurons in the mouse results in seizures,
macrocephaly
, social interaction deficits and anxiety, reminiscent of human
autism
spectrum disorder. Here we extended our previous examination of these mice using electroencephalogram/electromyogram (EEG/EMG) monitoring and found age-related increases in spontaneous seizures, which were correlated with cellular dispersion in the hippocampal dentate gyrus. Increased spontaneous locomotor activity in the open field on the first and the second day of a 3-day continuous study suggested heightened anxiety in Pten mutant mice. In contrast, the mutants exhibited decreased wheel running activity, which may reflect reduced adaptability to a novel environment. Synchronization to the light-dark cycle was normal, but for up to 28 days under constant darkness, the Pten mutants maintained a significantly lengthened and remarkably constant free-running period of almost exactly 24 h. This result implies the involvement of Pten in the maintenance of circadian rhythms, which we interpret as being due to an effect on the phosphatidylinositol 3-kinase (PI3K) signaling cascade.
...
PMID:A seizure-prone phenotype is associated with altered free-running rhythm in Pten mutant mice. 1770 14
Data on the growth of the head in the first year of life in children with
autism
spectrum disorders are inconsistent. We measured head circumference and body length during the first year of life, and determined whether the head grew in proportion to body length. This is a case-control study nested in a population-based screening study of
autism
spectrum disorders. Longitudinal data for head circumference and body length of 53 children with
autism
spectrum disorders were compared with those of a control group and population norms, using univariate and multilevel statistical modeling. Growth of body length was accelerated, but growth of head circumference was normal in children with
autism
spectrum disorders compared with controls in the first year of life. The rate of
macrocephaly
we detected in the first year of life in our sample, 11.3%, fits within the 95% confidence intervals of
macrocephaly
rates in previous studies. Our findings suggest that
autism
spectrum disorder is due to a dysregulation of growth in general, rather than to a dysregulation of neuronal growth in the brain. It is unclear whether this early, disproportionate growth of children with
autism
spectrum disorders is specific to the disorder, and whether this growth could serve as a biomarker to delineate more homogeneous subtypes of
autism
spectrum disorders.
...
PMID:Body length and head growth in the first year of life in autism. 1795 Apr 17
L-2-Hydroxyglutaric aciduria (L-2-HGA) is an autosomal recessive neurometabolic disorder characterized by psychomotor delay, ataxia,
macrocephaly
and typical neuroradiological findings of subcortical leucoencephalopathy. Recently, the disease causing gene has been discovered (L2HGDH) encoding L-2-hydroxyglutarate dehydrogenase. We present a 3-year-old boy with L-2-HGA, who demonstrated
macrocephaly
, noted already in utero with ultrasound. Cranial MRI demonstrated diffuse subcortical encephalopathy with increased signal of the subcortical white matter. Subsequent metabolic screening revealed increased levels of L-2-HGA, and genomic DNA analysis demonstrated two missense mutations in L-2-HGDG. Patient's further motor development was mildly impaired, whilst his speech development was profoundly impaired (first words at the age of 2 years). Since the age of 2 years he started demonstrating autistic repetitive behaviors and movements, increasing aloofness to his environment and limitations in the variety of spontaneous activity (CARS score: 44/60-severe
autism
).
Autism
has not so far been described in L-2-HGA and may be considered as an additional feature of the phenotypic spectrum.
...
PMID:L-2-Hydroxyglutaric aciduria presenting with severe autistic features. 1798 16
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>